Literature DB >> 17248561

On the Genetic Control of Genes Located in the Sex-Chromosome Heterochromatin of DROSOPHILA MELANOGASTER.

L Sandler1.   

Abstract

The genetic properties of a recessive autosomal point mutant, "daughterless" (symbol: da), are described. They are: (1) da maps in the euchromatin of 2L at about position 39 on the genetic map and between 27D and 31E on the salivary map; (2) when homozygous in females, da causes the production of unisexual male progenies owing to sex differential zygote mortality in the egg stage; (3) da has no effect on the progeny of mutant males; (4) female zygotes die, while at least some male zygotes survive, irrespective of the number of Y chromosomes or the amount of X-chromosome heterochromatin carried by either the mutant female or her progeny; (5) homozygous da progeny of heterozygous parents also show sex differential survival favoring males indicating a da effect in development as well as in oogenesis, but with the developmental effect much less pronounced; (6) extra heterochromatin from either the X or Y chromosome in either the mother or her progeny can reduce the mortality caused by da in development (and, therefore, conceivably can also reduce the abnormality in oogenesis, although this is obscured by the severity of the maternal effect.)-From these results, it is suggested that (1) da regulates either the activity of structural genes in the sex chromosome heterochromatin or the activity or stability of their products, and (2) it is a defective product of sex chromosome heterochromatic genes that causes the abnormalities resulting in the observed mortality of heterozygous progeny of homozygous mutant mothers and of homozygous mutant progeny of heterozygous mothers.-The striking parallels with the properties of the gene, "abnormal oocyte" are noted as is the close linkage between the two loci. The possibility of a special sex-chromosome-heterochromatin-regulator region on chromosome 2 is considered.

Entities:  

Year:  1972        PMID: 17248561      PMCID: PMC1212732     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  1 in total

1.  Some aspects of the bobbed problem in Drosophila.

Authors:  K C Atwood
Journal:  Genetics       Date:  1969       Impact factor: 4.562

  1 in total
  8 in total

1.  Daughters from daughterless mothers - Rescuing a female-lethal maternal effect by cytoplasmic transplantation inDrosophila embryos.

Authors:  M Bownes; Thomas W Cline; Howard A Schneiderman
Journal:  Wilehm Roux Arch Dev Biol       Date:  1977-09

2.  Lindsley and Sandler et al. on Gene Dosage and the Drosophila Genome.

Authors:  Mariana F Wolfner
Journal:  Genetics       Date:  2016-04       Impact factor: 4.562

3.  A note on the maternal effect mutants daughterless and abnormal oocyte in Drosophila melanogaster.

Authors:  A P Mange; L Sandler
Journal:  Genetics       Date:  1973-01       Impact factor: 4.562

4.  Genetic analysis of the heterochromatin of chromosome 3 in Drosophila melanogaster. I. Products of compound-autosome detachment.

Authors:  G E Marchant; D G Holm
Journal:  Genetics       Date:  1988-10       Impact factor: 4.562

5.  Two closely linked mutations in Drosophila melanogaster that are lethal to opposite sexes and interact with daughterless.

Authors:  T W Cline
Journal:  Genetics       Date:  1978-12       Impact factor: 4.562

6.  Multiple vital functions of the daughterless (da) gene in Drosophila melanogaster and factors influencing its expression.

Authors:  W M Muir; A E Bell
Journal:  Genetica       Date:  1987-05-15       Impact factor: 1.082

7.  A genetic analysis of hermaphrodite, a pleiotropic sex determination gene in Drosophila melanogaster.

Authors:  M A Pultz; G S Carson; B S Baker
Journal:  Genetics       Date:  1994-01       Impact factor: 4.562

Review 8.  Sex and the single cell. I. On the action of major loci affecting sex determination in Drosophila melanogaster.

Authors:  B S Baker; K A Ridge
Journal:  Genetics       Date:  1980-02       Impact factor: 4.562

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.